| Drug group | Mechanism | Exam points |
|---|---|---|
| UFH Unfractionated heparin |
Binds antithrombin → Inhibits thrombin (FIIa) and FXa | Short half-life; useful in renal failure/high bleeding risk; monitor aPTT if therapeutic dose; HIT risk |
| LMWH e.g. enoxaparin, dalteparin |
Binds antithrombin → Mainly inhibits FXa | Common surgical prophylaxis; predictable effect; renal dose adjustment; lower HIT risk than UFH |
| Fondaparinux | Synthetic pentasaccharide → Antithrombin-mediated FXa inhibition | Not LMWH; avoid in severe renal failure; useful alternative in selected patients |
| Warfarin / coumarin | Inhibits vitamin K epoxide reductase → ↓ FII, VII, IX, X, protein C/S | Slow action; INR monitoring; many food/drug interactions; bridge needed for acute VTE start |
| DOACs | Dabigatran → Direct FIIa inhibitor Rivaroxaban/apixaban/edoxaban → Direct FXa inhibitors |
No routine INR; renal function matters; used for VTE treatment and selected prophylaxis, especially orthopedic surgery |